Use of tumor factor inhibitors together with antiviral agents and therapeutic compositions thereof against HIV infection
US6001828A · kind A · utility
8Cited by
1References
1Claims
0Family size
Inventors
Key dates
| Filing date | Oct 23, 1997 |
| Grant date | Dec 14, 1999 |
| Priority date | — |
| Expiry date | Oct 23, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprising: (a) a tumor necrosis factor inhibitor; (b) a compound selected from the group consisting of reverse transcriptase inhibitors, protease inhibitor, a gene inhibitor, myristoylation inhibitors, cell-virus binding inhibitors, LTR promoter site inhibitors, ribosome inactivators, platelet aggregation inhibitors and prophylactic and therapeutic HIV vaccines, and (c) a pharmaceutical inert nontoxic carrier are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.